Last 46 quarters of trend data · Basic Materials · Chemicals - Specialty
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Ingevity Corporation's quarterly P/E stands at 10.7x, down 39.3% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has expanded 24.2% YoY to 10.0x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -15.61 | 10.73 | — | 11.69 | — | 17.67 | 22.64 | — | — | — | — | 17.25 | 14.99 |
| — | -39.3% | — | — | — | — | — | — | — | — | — | +125.3% | +46.2% | |
| P/S Ratio | 2.17 | 2.48 | 2.07 | 1.53 | 1.07 | 1.28 | 1.25 | 0.94 | 1.02 | 1.27 | 1.15 | 0.97 | 1.10 |
| — | +94.5% | +65.9% | +63.0% | +5.7% | +0.5% | +8.5% | -3.2% | -7.9% | -25.6% | -33.6% | -18.9% | -24.2% | |
| P/B Ratio | 87.73 | 65.92 | 71.14 | 14.79 | 12.99 | 6.19 | 7.64 | 6.61 | 5.58 | 3.04 | 2.71 | 2.41 | 2.98 |
| — | +965.4% | +831.0% | +123.8% | +133.0% | +103.2% | +182.2% | +174.1% | +87.1% | -17.7% | -28.8% | -33.9% | -20.3% | |
| P/FCF | 9.27 | — | 7.19 | 4.33 | 5.87 | 23.56 | 9.42 | 12.43 | 34.23 | — | 27.75 | 6.04 | 19.93 |
| — | — | -23.7% | -65.1% | -82.9% | — | -66.1% | +105.8% | +71.7% | — | +104.8% | -33.1% | +98.4% | |
| EV / EBITDA | 10.05 | 10.01 | 12.30 | 7.50 | 6.43 | 8.06 | 8.95 | 6.41 | 7.48 | 10.62 | 23.15 | 9.22 | 7.13 |
| — | +24.2% | +37.5% | +17.0% | -14.0% | -24.1% | -61.3% | -30.5% | +4.9% | +6.1% | +30.7% | +53.2% | -3.8% | |
| EV / EBIT | 14.13 | 13.31 | — | 10.08 | — | 14.82 | 20.98 | — | — | — | — | 14.26 | 12.96 |
| — | -10.2% | — | — | — | — | — | — | — | — | — | +80.0% | +37.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Ingevity Corporation's operating margin was 26.7% in Q1 2026, up 11.5 pp QoQ and up 4.7 pp YoY. The trailing four-quarter average of 22.6% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin expanded 13.0% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.5% | 45.1% | 34.4% | 40.2% | 37.8% | 39.9% | 34.1% | 34.5% | 31.5% | 29.3% | 16.0% | 28.9% | 29.3% |
| — | +13.0% | +0.9% | +16.6% | +19.7% | +36.2% | +113.0% | +19.2% | +7.6% | -11.7% | -42.2% | -16.3% | -18.3% | |
| Operating Margin | 22.4% | 26.7% | 15.2% | 24.9% | 23.5% | 22.0% | 18.5% | 22.4% | 19.1% | 13.4% | 2.4% | — | 19.1% |
| — | +21.3% | -17.7% | +10.9% | +23.4% | +64.0% | +671.5% | — | -0.2% | -27.7% | -73.5% | — | -14.4% | |
| Net Margin | -14.3% | 23.2% | -33.2% | 13.1% | -40.1% | 7.2% | 5.6% | -28.4% | -72.6% | -16.5% | -31.4% | 5.7% | 7.4% |
| — | +221.1% | -696.9% | +145.9% | +44.8% | +143.8% | +117.7% | -603.4% | -1086.4% | -227.5% | -872.7% | -63.8% | -48.3% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -148.6% | 174.3% | -100.8% | 33.6% | -82.5% | 9.5% | 8.1% | -42.9% | -66.5% | -9.3% | -17.3% | 3.5% | 4.9% |
| — | +1727.6% | -1344.3% | +178.3% | -24.0% | +202.2% | +146.8% | -1320.7% | -1448.9% | -231.1% | -838.8% | -70.0% | -44.7% | |
| ROA | -9.1% | 3.6% | -4.9% | 2.3% | -7.4% | 1.0% | 0.8% | -4.8% | -11.7% | -2.2% | -4.3% | 0.9% | 1.3% |
| — | +260.4% | -719.2% | +149.1% | +36.4% | +146.6% | +118.1% | -630.4% | -1024.2% | -217.2% | -804.5% | -71.9% | -48.9% | |
| ROIC | 14.2% | 4.4% | 2.3% | 4.5% | 4.3% | 2.9% | 2.6% | 3.8% | 3.0% | 1.7% | 0.3% | — | 3.1% |
| — | +50.0% | -11.0% | +19.6% | +44.1% | +76.5% | +718.6% | — | -4.8% | -33.5% | -76.3% | — | -21.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Ingevity Corporation's Debt/EBITDA ratio is 13.1x, down from 18.7x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 29.1% YoY to 1.42x, tightening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 41.84 | 30.96 | 41.84 | 9.35 | 11.40 | 6.15 | 7.45 | 7.26 | 5.49 | 2.74 | 2.43 | 2.15 | 2.23 |
| — | +403.6% | +461.5% | +28.9% | +107.5% | +124.3% | +206.6% | +238.2% | +146.2% | +27.5% | +10.9% | +13.1% | +18.8% | |
| Debt / EBITDA | 3.37 | 13.13 | 18.66 | 11.92 | 12.34 | 16.48 | 18.09 | 14.06 | 15.37 | 20.68 | 45.13 | 17.82 | 12.44 |
| — | -20.3% | +3.1% | -15.2% | -19.7% | -20.3% | -59.9% | -21.1% | +23.6% | +38.0% | +71.0% | +112.0% | +21.0% | |
| Current Ratio | 1.15 | 1.42 | 1.15 | 1.27 | 1.36 | 2.00 | 1.87 | 1.76 | 1.92 | 1.90 | 1.81 | 2.41 | 2.46 |
| — | -29.1% | -38.6% | -28.1% | -28.9% | +5.3% | +2.9% | -26.7% | -22.0% | -25.9% | -19.4% | +8.3% | -3.1% | |
| Quick Ratio | 0.60 | 0.92 | 0.60 | 0.80 | 0.80 | 1.08 | 1.01 | 1.04 | 1.07 | 0.98 | 0.96 | 1.14 | 1.21 |
| — | -14.1% | -40.4% | -23.4% | -25.1% | +10.1% | +4.6% | -8.6% | -11.6% | -23.2% | -16.0% | -8.9% | -19.1% | |
| Interest Coverage | -0.94 | 4.34 | -5.31 | 4.15 | -6.23 | 2.29 | 1.35 | -4.61 | -12.88 | -2.09 | -4.90 | 2.35 | 3.09 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 46 years · Updated daily
Total return calculator · dividends reinvested
Calculate ReturnsDollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Compare NowQuick answers to the most common questions about buying NGVT stock.
Ingevity Corporation's current P/E is -15.6x. The average P/E over the last 2 quarters is 11.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Ingevity Corporation's current operating margin is 22.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Ingevity Corporation's business trajectory between earnings reports.